MURAKAMI; Masataka
Patent Applications and Registrations
Patent applications and USPTO patent grants for MURAKAMI; Masataka.The latest application filed is for "heterocyclic compound".
- MURAKAMI; Masataka - Kanagawa JP
- MURAKAMI; Masataka - Fujisawa-shi JP
- Murakami; Masataka - Fujisawa JP
- Murakami; Masataka - Osaka JP
| Patent | Date |
|---|---|
| Heterocyclic Compound App 20220289679 - TANAKA; Yuta ; et al. | 2022-09-15 |
| Heterocyclic Compound App 20220274982 - TANAKA; Yuta ; et al. | 2022-09-01 |
| Heterocyclic Compound And Use Thereof App 20220089525 - OGURO; Yuya ; et al. | 2022-03-24 |
| Heterocyclic compound Grant 11,274,101 - Kamata , et al. March 15, 2 | 2022-03-15 |
| Heterocyclic compound Grant 11,242,348 - Kamata , et al. February 8, 2 | 2022-02-08 |
| Heterocyclic compound Grant 11,236,099 - Takami , et al. February 1, 2 | 2022-02-01 |
| Heterocyclic Compound App 20220017530 - Takami; Kazuaki ; et al. | 2022-01-20 |
| Heterocyclic Compound And Use Thereof App 20210332053 - OGURO; Yuya ; et al. | 2021-10-28 |
| Heterocyclic Compound App 20210139491 - TAKAMI; Kazuaki ; et al. | 2021-05-13 |
| Heterocyclic Compound App 20210087186 - TANAKA; Yuta ; et al. | 2021-03-25 |
| 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor Grant 10,899,752 - Sugimoto , et al. January 26, 2 | 2021-01-26 |
| Heterocyclic compound and use thereof Grant 10,807,987 - Oguro , et al. October 20, 2 | 2020-10-20 |
| Heterocyclic Compound App 20200255439 - Kind Code | 2020-08-13 |
| Heterocyclic compound Grant 10,610,520 - Ikeda , et al. | 2020-04-07 |
| Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity Grant 10,548,899 - Sugimoto , et al. Fe | 2020-02-04 |
| Heterocyclic Compound And Use Thereof App 20190300536 - OGURO; Yuya ; et al. | 2019-10-03 |
| Heterocyclic compound Grant 10,428,056 - Sugimoto , et al. October 1, 2 | 2019-10-01 |
| 2,3-dihydro-4h-1,3-benzoxazin-4-one Derivatives As Modulators Of Cholinergic Muscarinic M1 Receptor App 20190248776 - SUGIMOTO; Takahiro ; et al. | 2019-08-15 |
| Heterocyclic compound Grant 10,323,026 - Ikeda , et al. | 2019-06-18 |
| 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor Grant 10,323,027 - Sugimoto , et al. | 2019-06-18 |
| Heterocyclic Compound App 20190125728 - IKEDA; Shuhei ; et al. | 2019-05-02 |
| Nitrogen-containing heterocyclic compound Grant 10,208,046 - Sugimoto , et al. Feb | 2019-02-19 |
| Heterocyclic Compound App 20180303841 - SUGIMOTO; Takahiro ; et al. | 2018-10-25 |
| 2,3-dihydro-4h-1,3-benzoxazin-4-one Derivatives As Modulators Of Cholinergic Muscarinic M1 Receptor App 20180162850 - SUGIMOTO; Takahiro ; et al. | 2018-06-14 |
| Heterocyclic compound Grant 9,878,989 - Sugimoto , et al. January 30, 2 | 2018-01-30 |
| Heterocyclic Compound App 20170283406 - Ikeda; Shuhei ; et al. | 2017-10-05 |
| Nitrogen-containing Heterocyclic Compound App 20170081332 - SUGIMOTO; Takahiro ; et al. | 2017-03-23 |
| Heterocyclic Compound App 20160376244 - SUGIMOTO; Takahiro ; et al. | 2016-12-29 |
| Bicyclic compound Grant 8,703,758 - Yamashita , et al. April 22, 2 | 2014-04-22 |
| Bicyclic Compound App 20120142714 - YASUMA; TSUNEO ; et al. | 2012-06-07 |
| Bicyclic Compound App 20110263562 - Yamashita; Tohru ; et al. | 2011-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 